Annual Retained Earnings
-$371.26 M
-$41.24 M-12.50%
01 June 2022
Summary:
Pluristem Therapeutics annual retained earnings is currently -$371.26 million, with the most recent change of -$41.24 million (-12.50%) on 01 June 2022. During the last 3 years, it has fallen by -$41.24 million (-12.50%).PSTI Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$377.38 M
-$6.12 M-1.65%
01 September 2022
Summary:
Pluristem Therapeutics quarterly retained earnings is currently -$377.38 million, with the most recent change of -$6.12 million (-1.65%) on 01 September 2022.PSTI Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -12.5% | -10.5% |
| 5 y5 years | -47.9% | -46.2% |
PSTI Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | >+9999.0% | >+9999.0% |
Pluristem Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -$377.38 M(+1.6%) |
| June 2022 | -$371.26 M(+12.5%) | -$371.26 M(+2.5%) |
| Mar 2022 | - | -$362.26 M(+2.8%) |
| Dec 2021 | - | -$352.39 M(+3.2%) |
| Sept 2021 | - | -$341.45 M(+3.5%) |
| June 2021 | -$330.02 M(+17.8%) | -$330.02 M(+4.6%) |
| Mar 2021 | - | -$315.45 M(+4.7%) |
| Dec 2020 | - | -$301.20 M(+4.3%) |
| Sept 2020 | - | -$288.64 M(+3.0%) |
| June 2020 | -$280.16 M(+11.6%) | -$280.16 M(+3.0%) |
| Mar 2020 | - | -$272.02 M(+2.8%) |
| Dec 2019 | - | -$264.51 M(+2.5%) |
| Sept 2019 | - | -$258.14 M(+2.8%) |
| June 2019 | -$251.00 M(+16.4%) | -$251.00 M(+3.2%) |
| Mar 2019 | - | -$243.24 M(+4.3%) |
| Dec 2018 | - | -$233.17 M(+3.9%) |
| Sept 2018 | - | -$224.48 M(+4.1%) |
| June 2018 | -$215.70 M(+13.8%) | -$215.70 M(+4.3%) |
| Mar 2018 | - | -$206.72 M(+0.7%) |
| Dec 2017 | - | -$205.19 M(+4.2%) |
| Sept 2017 | - | -$196.96 M(+3.9%) |
| June 2017 | -$189.57 M(+17.2%) | -$189.57 M(+3.8%) |
| Mar 2017 | - | -$182.56 M(+4.5%) |
| Dec 2016 | - | -$174.69 M(+3.9%) |
| Sept 2016 | - | -$168.08 M(+3.9%) |
| June 2016 | -$161.76 M(+16.8%) | -$161.76 M(+4.0%) |
| Mar 2016 | - | -$155.55 M(+4.9%) |
| Dec 2015 | - | -$148.35 M(+2.7%) |
| Sept 2015 | - | -$144.39 M(+4.2%) |
| June 2015 | -$138.51 M(+21.7%) | -$138.51 M(+4.0%) |
| Mar 2015 | - | -$133.22 M(+5.7%) |
| Dec 2014 | - | -$125.99 M(+5.2%) |
| Sept 2014 | - | -$119.75 M(+5.2%) |
| June 2014 | -$113.83 M(+31.0%) | -$113.83 M(+5.8%) |
| Mar 2014 | - | -$107.64 M(+9.4%) |
| Dec 2013 | - | -$98.36 M(+7.3%) |
| Sept 2013 | - | -$91.66 M(+5.5%) |
| June 2013 | -$86.90 M(+32.2%) | -$86.90 M(+8.7%) |
| Mar 2013 | - | -$79.91 M(+7.7%) |
| Dec 2012 | - | -$74.23 M(+6.4%) |
| Sept 2012 | - | -$69.74 M(+6.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | -$65.75 M(+29.0%) | -$65.75 M(+6.7%) |
| Mar 2012 | - | -$61.61 M(+7.3%) |
| Dec 2011 | - | -$57.44 M(+3.6%) |
| Sept 2011 | - | -$55.45 M(+8.8%) |
| June 2011 | -$50.95 M(+27.0%) | -$50.95 M(+7.9%) |
| Mar 2011 | - | -$47.23 M(+5.9%) |
| Dec 2010 | - | -$44.62 M(+6.7%) |
| Sept 2010 | - | -$41.79 M(+4.2%) |
| June 2010 | -$40.10 M(+22.8%) | -$40.10 M(+4.5%) |
| Mar 2010 | - | -$38.36 M(+6.3%) |
| Dec 2009 | - | -$36.10 M(+5.3%) |
| Sept 2009 | - | -$34.27 M(+5.0%) |
| June 2009 | -$32.65 M(+25.5%) | -$32.65 M(+5.0%) |
| Mar 2009 | - | -$31.09 M(+6.9%) |
| Dec 2008 | - | -$29.09 M(+2.9%) |
| Sept 2008 | - | -$28.26 M(+8.6%) |
| June 2008 | -$26.02 M(+67.7%) | -$26.02 M(+13.4%) |
| Mar 2008 | - | -$22.95 M(+12.9%) |
| Dec 2007 | - | -$20.33 M(+14.2%) |
| Sept 2007 | - | -$17.80 M(+14.7%) |
| June 2007 | -$15.52 M(+118.9%) | -$15.52 M(+29.6%) |
| Mar 2007 | - | -$11.98 M(+48.7%) |
| Dec 2006 | - | -$8.06 M(+9.3%) |
| Sept 2006 | - | -$7.37 M(+4.0%) |
| June 2006 | -$7.09 M(+52.5%) | -$7.09 M(+15.5%) |
| Mar 2006 | - | -$6.14 M(+11.4%) |
| Dec 2005 | - | -$5.51 M(+9.7%) |
| Sept 2005 | - | -$5.02 M(+8.1%) |
| June 2005 | -$4.65 M(+82.2%) | -$4.65 M(-0.7%) |
| Mar 2005 | - | -$4.68 M(+43.6%) |
| Dec 2004 | - | -$3.26 M(+14.1%) |
| Sept 2004 | - | -$2.86 M(+12.0%) |
| June 2004 | -$2.55 M(+371.7%) | -$2.55 M(+9.4%) |
| Mar 2004 | - | -$2.33 M(+89.0%) |
| Dec 2003 | - | -$1.23 M(+42.9%) |
| Sept 2003 | - | -$863.40 K(+59.6%) |
| June 2003 | -$540.90 K(+594.4%) | -$540.90 K(+332.4%) |
| Mar 2003 | - | -$125.10 K(+17.6%) |
| Dec 2002 | - | -$106.40 K(+8.4%) |
| Sept 2002 | - | -$98.20 K(+26.1%) |
| June 2002 | -$77.90 K | -$77.90 K |
FAQ
- What is Pluristem Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Pluristem Therapeutics?
What is Pluristem Therapeutics annual retained earnings?
The current annual retained earnings of PSTI is -$371.26 M
What is the all time high annual retained earnings for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual retained earnings is -$77.90 K
What is Pluristem Therapeutics quarterly retained earnings?
The current quarterly retained earnings of PSTI is -$377.38 M
What is the all time high quarterly retained earnings for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly retained earnings is -$77.90 K